Affiliation:
1. Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, USA
Abstract
ABSTRACT
The Rb1 tumor suppressor protein is a molecular adaptor that physically links transcription factors like E2f with various proteins acting on DNA or RNA to repress gene expression. Loss of Rb1 liberates E2f to activate the expression of genes mediating resulting phenotypes. Most Rb1 binding proteins, including E2f, interact through carboxyl-terminal protein interaction domains, but genetic evidence suggests that an amino-terminal protein interaction domain is also important. One protein that binds Rb1 through the amino-terminal domain is encoded by
Thoc1
, a required component of the THO ribonucleoprotein complex important for RNA processing and transport. The physiological relevance of this interaction is unknown. Here we tested whether
Thoc1
mediates effects of
Rb1
loss on mouse embryonic development. We found that
Thoc1
deficiency delays embryo death, and this delay correlates with reduced apoptosis in the brain. E2f protein levels are reduced in
Rb1
:
Thoc1
-deficient brain tissue. Expression of apoptotic regulatory genes regulated by E2f, like Apaf1 and Bak1, is also reduced. These observations suggest that
Thoc1
is required to support increased expression of E2f and apoptotic regulatory genes that trigger apoptosis upon
Rb1
loss. These findings implicate Rb1 in the regulation of the THO ribonucleoprotein complex.
Funder
University at Buffalo Mark Diamond Fund
HHS | NIH | National Cancer Institute
Publisher
American Society for Microbiology
Subject
Cell Biology,Molecular Biology
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献